{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:52:48Z","timestamp":1780451568007,"version":"3.54.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/inf.0000000000000694","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T14:40:51Z","timestamp":1428072051000},"page":"627-634","source":"Crossref","is-referenced-by-count":31,"title":["An Open-Label, Randomized Study of a 9-Valent Human Papillomavirus Vaccine Given Concomitantly with Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccines to Healthy Adolescents 11\u201315 Years of Age"],"prefix":"10.1097","volume":"34","author":[{"given":"Pope","family":"Kosalaraksa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Mehlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Vesikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aino","family":"Forst\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Helm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar A.","family":"Joura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ciprero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Maansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Luxembourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajoke","family":"Sobanjo-ter Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl 5","key":"R1-19-20210202","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases.","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"R2-19-20210202","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Females United to Unilaterally Reduce EndoEctocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women between 24 and 45 years of age: a randomized, double-blind trial.","volume":"373","author":"Munoz","year":"2009","journal-title":"Lancet"},{"key":"R5-19-20210202","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"R7-19-20210202","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"HPV PATRICIA study group. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"R8-19-20210202","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","article-title":"Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.","volume":"208","author":"Markowitz","year":"2013","journal-title":"J Infect Dis"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program.","volume":"206","author":"Tabrizi","year":"2012","journal-title":"J Infect Dis"},{"key":"R10-19-20210202","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study.","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"R11-19-20210202","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2012.10.092","article-title":"Impact of human papillomavirus (HPV) vaccination on HPV 1618-related prevalence in precancerous cervical lesions.","volume":"31","author":"Powell","year":"2012","journal-title":"Vaccine"},{"key":"R12-19-20210202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1741-7015-11-227","article-title":"Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.","volume":"11","author":"Gertig","year":"2013","journal-title":"BMC Med"},{"key":"R13-19-20210202","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ"},{"key":"R14-19-20210202","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-13-140","article-title":"Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program.","volume":"13","author":"Ali","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R15-19-20210202","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":"The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme.","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"R17-19-20210202","first-page":"17","article-title":"Incidence of genital warts among U.S. service members before and after the introduction of the quadrivalent human papillomavirus vaccine.","volume":"20","author":"Nsouli-Maktabi","year":"2013","journal-title":"MSMR"},{"key":"R18-19-20210202","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/jis405","article-title":"Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.","volume":"206","author":"Leval","year":"2012","journal-title":"J Infect Dis"},{"key":"R19-19-20210202","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","article-title":"Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.","volume":"40","author":"Baandrup","year":"2013","journal-title":"Sex Transm Dis"},{"key":"R20-19-20210202","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/OLQ.0b013e3182756efd","article-title":"Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study.","volume":"40","author":"Mikolajczyk","year":"2013","journal-title":"Sex Transm Dis"},{"key":"R21-19-20210202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/cit436","article-title":"Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark.","volume":"57","author":"Blomberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R22-19-20210202","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2334-14-87","article-title":"Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling.","volume":"14","author":"Delere","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R23-19-20210202","doi-asserted-by":"crossref","first-page":"djt460","DOI":"10.1093\/jnci\/djt460","article-title":"Early impact of human papillomavirus vaccination on cervical neoplasia-nationwide follow-up of young Danish women.","volume":"106","author":"Baldur-Felskov","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R24-19-20210202","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vaccine.2013.10.085","article-title":"Reduction in HPV 1618 prevalence in sexually active young women following the introduction of HPV immunisation in England.","volume":"32","author":"Mesher","year":"2013","journal-title":"Vaccine"},{"key":"R25-19-20210202","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/bjc.2014.198","article-title":"Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 1618 and closely related HPV types.","volume":"110","author":"Kavanagh","year":"2014","journal-title":"Br J Cancer"},{"key":"R27-19-20210202","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-7-38","article-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease.","volume":"7","author":"Serrano","year":"2012","journal-title":"Infect Agent Cancer"},{"key":"R29-19-20210202","first-page":"1","article-title":"Advisory Committee on Immunization Practices (ACIP). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 5","key":"R31-19-20210202","doi-asserted-by":"crossref","first-page":"F139","DOI":"10.1016\/j.vaccine.2012.05.039","article-title":"Human papillomavirus vaccine introduction-the first five years.","volume":"30","author":"Markowitz","year":"2012","journal-title":"Vaccine"},{"key":"R32-19-20210202","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/INF.0b013e3181c177fb","article-title":"An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent HPV (types 6111618) vaccine given concomitantly with diphtheria, tetanus, pertussis and poliomyelitis vaccine in healthy adolescents 11-17 years of age.","volume":"29","author":"Vesikari","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R33-19-20210202","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.4161\/hv.29205","article-title":"Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.","volume":"10","author":"Roberts","year":"2014","journal-title":"Hum Vaccin Immunother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:06:51Z","timestamp":1620954411000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201506000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000694","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}